Navigation Links
Study Says Using the da Vinci Surgical Robot for a Hysterectomy Fails to Cut Complications and May Raise Pneumonia Risk, Notes Parker Waichman LLP

New York, NY (PRWEB) September 11, 2013

Parker Waichman LLP, a national law firm dedicated to protecting the rights of victims injured by defective medical devices, notes that a Sept. 10 Bloomberg report details a study that reveals using the da Vinci surgical robot to perform a hysterectomy doesn’t reduce complications and could possibly raise the risk of pneumonia when compared with the use of conventional surgical techniques. For the study, researchers examined data from about 16,000 women who had hysterectomies for benign conditions in 2009 and 2010, Bloomberg added.

Operations performed with the da Vinci surgical robot cost hospitals $2,489 more per procedure but have a similar complication rate when compared with the standard practice of removing the uterus with minimally invasive equipment, according to the study, as Bloomberg reported. “Unfortunately, the greater costs associated with robotic-assisted hysterectomy were not reflected in improvement in outcomes,” researchers at the University of Texas Southwestern Medical Center at Dallas, who conducted the study, told Bloomberg.

The increased risk of pneumonia finding could be due to the large number of robotic hysterectomy patients who need intubation after their operation, Bloomberg reported. During robotic hysterectomies, patients are positioned at a steep angle, with their heads down. This could cause fluid to build up in the airways, Bloomberg reported the study as suggesting.

The da Vinci surgical robot’s safety and cost effectiveness have been under scrutiny, according to a July 19 Bloomberg report. In February, U.S. regulators started surveying surgeons about the robots following a rise in adverse event reports that included as many as 70 deaths since 2009. In that same report, Bloomberg noted that the U.S. Food and Drug Administration (FDA) sent a warning letter on July 17 to Intuitive Surgical after inspections in April and May by the agency found some problems, including the company’s failure to adequately report device corrections and patient adverse events.

Bloomberg also noted in the report that the da Vinci surgical robot, which is used in more than 1,300 hospitals, has been the subject of negligence lawsuits alleging that patients were injured during surgeries with the device. Cancer surgery, hysterectomies and gall bladder removals are among the main procedures performed with da Vinci surgical robot, the report added.

Parker Waichman LLP continues to offer free legal consultations to victims of injuries allegedly caused by the da Vinci surgical robot. If you or a loved one experienced surgical burns, perforated or torn organs, torn blood vessels or other injuries that could be associated with the da Vinci surgical robot, please contact their office by visiting the firm's da Vinci Surgical Robot Lawsuit page at Free case evaluations are also available by calling 1 800 LAW INFO (1-800-529-4636).

Parker Waichman LLP
Gary Falkowitz, Managing Attorney
1+(800) LAW-INFO
1+(800) 529-4636

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Da Vinci Robot Lawsuit Lawyers at Wright & Schulte LLC Disturbed by New Study Examining Risks and Benefits of Robotic Surgery Hysterectomy
2. American families taking divergent paths, study finds
3. Da Vinci Robot Lawsuit News: Bernstein Liebhard LLP Comments on New Study Findings that Casts Doubt on Robot-Assisted Hysterectomy
4. Study: Redefining the Criteria for ALK Positive Lung Cancer
5. Study: Redefining the criteria for ALK positive lung cancer
6. UCI-led study creates new memories by directly changing the brain
7. Study identifies fibroblast growth factor 18 as an ovarian cancer biomarker
8. Study Indicates Benefits of Stem Cells in Treating MS Declines With Donor’s Age
9. Study uncovers value of mammogram screening for younger women
10. ACR, SBI on cancer study: More breast cancer screening needed in younger women
11. MERS-CoV treatment effective in monkeys, NIH study finds
Post Your Comments:
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
(Date:6/24/2016)... ... June 24, 2016 , ... Strategic Capital ... area economy by obtaining investment capital for emerging technology companies. SCP has ... have already resulted in more than a million dollars of capital investment for ...
(Date:6/24/2016)... ... 2016 , ... Today, MTI-GlobalStem, a provider of optimized transfection ... to transfect cells, announces its launch of the PluriQ™ G9™ Gene Editing System ... is a complete system for culturing and transfecting human pluripotent stem cells for ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), ... company,s second affiliate in Latin America . ... ... Colombia ... ...
(Date:6/23/2016)... 23, 2016 The vast majority of dialysis ... facility.  Treatments are usually 3 times a week, with ... including travel time, equipment preparation and wait time.  This ... grueling for patients who are elderly and frail.  Many ... and rehabilitation centers for some duration of time. ...
(Date:6/23/2016)... The Biotechnology industry might still ... great opportunities to investors. assesses the recent performances ... XON ), Vertex Pharmaceuticals Inc. (NASDAQ: ... ARNA ), and Regeneron Pharmaceuticals Inc. (NASDAQ: ... your complimentary trade alerts at: ...
Breaking Medicine Technology: